These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35104881)

  • 1. Effectiveness and Tolerability of Dronabinol Use in Patients with Chronic Pain: A Retrospective Analysis of 12-Week Open-Label Real-World Data Provided by the German Pain e-Registry.
    Ueberall MA; Horlemann J; Schuermann N; Kalaba M; Ware MA
    Pain Med; 2022 Aug; 23(8):1409-1422. PubMed ID: 35104881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Effectiveness and Tolerability of Nabiximols (THC:CBD) Oromucosal Spray versus Oral Dronabinol (THC) as Add-on Treatment for Severe Neuropathic Pain in Real-World Clinical Practice: Retrospective Analysis of the German Pain e-Registry.
    Ueberall MA; Essner U; Vila Silván C; Mueller-Schwefe GHH
    J Pain Res; 2022; 15():267-286. PubMed ID: 35140513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of the antispasmodic, pridinol, in patients with muscle-pain - results of primepain, a retrospective analysis of open-label real-world data provided by the German pain E-registry.
    Überall MA; Müller-Schwefe GHH; Horlemann J
    Curr Med Res Opin; 2022 Jul; 38(7):1203-1217. PubMed ID: 35575167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COMET - effectiveness and tolerability of methocarbamol versus oral opioid-analgesics as add-on measure in patients with non-specific low back pain refractory to recommended 1st line treatments. A retrospective analysis of depersonalized propensity score matched open-label real-world 4-week data from the German Pain e-Registry.
    Ueberall MA; Mueller-Schwefe G
    Curr Med Res Opin; 2022 Feb; 38(2):237-253. PubMed ID: 34767467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry.
    Ueberall MA; Essner U; Mueller-Schwefe GH
    J Pain Res; 2019; 12():1577-1604. PubMed ID: 31190969
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness, Safety, and Tolerability of Nabiximols Oromucosal Spray vs Typical Oral Long-Acting Opioid Analgesics in Patients with Severe Neuropathic Back Pain: Analysis of 6-Month Real-World Data from the German Pain e-Registry.
    Ueberall MA; Vila Silván C; Essner U; Mueller-Schwefe GHH
    Pain Med; 2022 Apr; 23(4):745-760. PubMed ID: 34480564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics.
    Johnson JR; Lossignol D; Burnell-Nugent M; Fallon MT
    J Pain Symptom Manage; 2013 Aug; 46(2):207-18. PubMed ID: 23141881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial.
    Ware MA; Wang T; Shapiro S; Robinson A; Ducruet T; Huynh T; Gamsa A; Bennett GJ; Collet JP
    CMAJ; 2010 Oct; 182(14):E694-701. PubMed ID: 20805210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Real-life efficacy and tolerability of methocarbamol in patients suffering from refractory muscle-related low/back pain - Results of a health care research project based on data from the German pain practice registry].
    Überall MA; Emrich OMD; Müller-Schwefe GHH
    MMW Fortschr Med; 2017 Dec; 159(Suppl 7):6-17. PubMed ID: 29204951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability.
    de Vries M; Van Rijckevorsel DC; Vissers KC; Wilder-Smith OH; Van Goor H
    Br J Clin Pharmacol; 2016 Mar; 81(3):525-37. PubMed ID: 26505163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dronabinol use in France between 2004 and 2017.
    Lejczak S; Rousselot H; Di Patrizio P; Debouverie M
    Rev Neurol (Paris); 2019 May; 175(5):298-304. PubMed ID: 30948262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-label, add-on study of tetrahydrocannabinol for chronic nonmalignant pain.
    Haroutiunian S; Rosen G; Shouval R; Davidson E
    J Pain Palliat Care Pharmacother; 2008; 22(3):213-7. PubMed ID: 19042851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study.
    de Vries M; van Rijckevorsel DCM; Vissers KCP; Wilder-Smith OHG; van Goor H;
    Clin Gastroenterol Hepatol; 2017 Jul; 15(7):1079-1086.e4. PubMed ID: 27720917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain.
    Yoon DH; Bin SI; Chan SK; Chung CK; In Y; Kim H; Lichauco JJ; Mok CC; Moon YW; Ng TK; Penserga EG; Shin DA; You D; Moon H
    BMC Musculoskelet Disord; 2017 Aug; 18(1):337. PubMed ID: 28778219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis-based medicines for chronic neuropathic pain in adults.
    Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lidocaine 700 mg medicated plaster for postherpetic neuralgia: real-world data from the German Pain e-Registry.
    Überall MA; Eerdekens M; Hollanders E; Bösl I; Sabatschus I
    Pain Manag; 2022 Mar; 12(2):195-209. PubMed ID: 34372662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal cord stimulation for chronic refractory pain: Long-term effectiveness and safety data from a multicentre registry.
    Brinzeu A; Cuny E; Fontaine D; Mertens P; Luyet PP; Van den Abeele C; Djian MC;
    Eur J Pain; 2019 May; 23(5):1031-1044. PubMed ID: 30597719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Italian registry on long-term intrathecal ziconotide treatment.
    Raffaeli W; Sarti D; Demartini L; Sotgiu A; Bonezzi C;
    Pain Physician; 2011; 14(1):15-24. PubMed ID: 21267038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Effectiveness and Tolerability of Pain Treatment with Tapentadol Prolonged Release.
    Mateos RG; Bernal DS; Morera LMT; Ferri CM; Escobar AE
    Pain Physician; 2021 Jan; 24(1):E75-E85. PubMed ID: 33400440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS).
    Ware MA; Wang T; Shapiro S; Collet JP;
    J Pain; 2015 Dec; 16(12):1233-1242. PubMed ID: 26385201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.